PRTCY (PureTech Health) Total Liabilities: $229.03 Mil (As of Dec. 2025)

What is PureTech Health Total Liabilities?

PureTech Health PRTCY +1.49% 62 Total Liabilities is $229.03 Mil as of Dec. 2025. GuruFocus rates PRTCY with a GF Score™ of 62/100 and a GF Value™ of $70.09 (Possible Value Trap). The stock has 4 warning signs investors should review.

PureTech Health's Total Liabilities for the quarter that ended in Dec. 2025 was $229.03 Mil.

PureTech Health's quarterly Total Liabilities declined from Dec. 2024 ($194.70 Mil) to Jun. 2025 ($184.22 Mil) but then increased from Jun. 2025 ($184.22 Mil) to Dec. 2025 ($229.03 Mil).

PureTech Health's annual Total Liabilities declined from Dec. 2023 ($235.74 Mil) to Dec. 2024 ($194.70 Mil) but then increased from Dec. 2024 ($194.70 Mil) to Dec. 2025 ($229.03 Mil).

PureTech Health Total Liabilities Related Terms

PureTech Health Total Liabilities Historical Data

* Premium members only.

The historical data trend for PureTech Health's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PureTech Health Total Liabilities Chart

PureTech Health Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Total Liabilities

Get a 7-Day Free Trial

361.86

155.06

235.74

194.70

229.03

PureTech Health Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Total Liabilities	Get a 7-Day Free Trial															235.74	273.74	194.70	184.22	229.03

62GF Score

PureTech Health PLC PRTCY

Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

PureTech Health Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

PureTech Health's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	46.309	+	(11.087	+	170.421
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	1.217	+	0)
	=	229.03

Total Liabilities	=	Total Assets (A: Dec. 2025 )	-	Total Equity (A: Dec. 2025 )
	=	534.71	-	305.676
	=	229.03

PureTech Health's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	46.309	+	(11.087	+	170.421
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	1.217	+	0)
	=	229.03

Total Liabilities	=	Total Assets (Q: Dec. 2025 )	-	Total Equity (Q: Dec. 2025 )
	=	534.71	-	305.676
	=	229.03

Frequently Asked Questions Learn more about Total Liabilities →

What does a Total Liabilities of $229.03 Mil mean?

PureTech Health (PRTCY) has a Total Liabilities of $229.03 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for PureTech Health and its competitors.

Is PureTech Health's Total Liabilities too high?

PureTech Health's current Total Liabilities is $229.03 Mil. Overall, PureTech Health has a GF Score™ of 62/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does PureTech Health's Total Liabilities compare to VRTX and REGN?

PureTech Health's Total Liabilities of $229.03 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Liabilities for a Biotechnology company?

A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Liabilities mean?

A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for PureTech Health and its competitors. PureTech Health's current Total Liabilities is $229.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is PureTech Health stock overvalued right now?

Based on GuruFocus' analysis, PureTech Health (PRTCY) is currently considered Possible Value Trap. The stock's GF Value™ is $70.09, compared to a current price of $17.54 — trading 75% below its estimated fair value. The current Total Liabilities is $229.03 Mil. PureTech Health's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Liabilities calculated?

Total Liabilities is calculated from a company's financial statements. For PureTech Health (PRTCY), the current Total Liabilities is $229.03 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PureTech Health (PRTCY) Overvalued in 2026?

Based on GuruFocus' analysis, PureTech Health stock appears to be undervalued. The current stock price of $17.54 is trading 75% below its estimated GF Value™ of $70.09. GuruFocus considers PureTech Health to be Possible Value Trap.

Key valuation signals for PRTCY:

Total Liabilities: $229.03 Mil
GF Value™: $70.09 vs. price of $17.54 (75% below fair value)
GF Score™: 62/100 with 4 warning signs

No single metric tells the full story. See the PRTCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PureTech Health Business Description

Industry Healthcare Biotechnology

Comparable Companies LSE:AVCT LSE:IBT LSE:SCLP LSE:FARN LSE:BVXP LSE:4BB LSE:HEMO LSE:COIL LSE:POLB LSE:SAR VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges PTCHF:USA PRTCl:UK PRTC:UK 0VQ:Germany

Address 6 Tide Street, Suite 400, Boston, MA, USA, 02210

Website https://www.puretechhealth.com

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

62GF Score

Get the complete analysis for PRTCY

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$17.54

Price

$70.09

GF Value

View PRTCY Analysis

See Total Liabilities data for all stocks →